MANCHESTER-BY-THE-SEA — Details of Danvers-based Cell Signaling Technology's plans to develop a campus off Atwater Avenue are expected to be revealed at a Planning Commission meeting scheduled for Monday night.
“The presentation will be an overview of the project, followed by a series of meetings to explain specific aspects of the project in more detail,” said Paul of Novus Public Affairs, the public relations firm hired to represent Cell Signaling Technology.・Mr. Young said.
Planning Commission Chairman Ronald Mastrogiacomo said Friday that Monday's meeting will be the first in a series of public hearings related to Cell Signaling Technology's application. The meeting is scheduled to begin at City Hall (10 Central St) at 6:30 p.m., but consideration of the development plan will not begin until 7 p.m.
“I think applicants spend the first 45 minutes outlining their project,” Mastrogiacomo said. “The board will then hear input. It's primarily for the public.”
Cell Signaling Technology was founded in 1999 and operates campuses on Trask Lane in Danvers and Tozer Road in Beverly. The company employs his more than 600 employees.
Cell Signaling Technology is proposing to build a scientific research and development facility on the site of an old granite quarry off Atwater Street. The site is adjacent to Route 128. The company has global headquarters in Danvers and production headquarters at 32 Tozer Road in Beverly.
After the initial presentation, Cell Signaling Technology team members will discuss the company's history and provide more details about the Manchester-by-the-Sea project, Mastrogiacomo said.
He said several experts will be in attendance, including at least one landscape architect.
Representatives from Redding-based design, engineering and environmental consulting firm Weston & Sampson Inc. will be in attendance to discuss drainage, roadways, site design and environmental issues.
Monday's hearing is scheduled to continue until a later date. The ultimate goal is to obtain site plan approval for the project, Mastrogiacomo said.
“It will take several months,” he said. “I hope it's over by June, but you never know. It's a big thing for Manchester. These guys are doing their homework.”
After Monday's meeting, the Planning Commission tentatively plans to meet on April 8 to consider the cell signal technology application, Mastrogiacomo said.
“The presentation will include a general discussion of the master plan, architectural and landscaping treatments, implementation of infrastructure and zoning requirements, sustainability, and access to open space elements of the project,” Young said. .
He noted that in a recent informal meeting with the Planning Commission, representatives from Cell Signaling Technology outlined plans for a sustainable research and development campus that would include “land remediation, landscaping, architectural treatments. “This project will restore a dilapidated gravel quarry and at the same time have a significant positive financial impact on the town.” ”
“This presentation will provide the board and the public with additional details regarding these benefits,” Young said.
He said the Planning Commission's review of the project is expected to take three to four months.
According to the company's website, Cell Signaling Technology is “a life sciences company of a different kind, owned and operated by practicing researchers and with over 20 years of experience in delivering the highest standards of product and service quality, technological innovation, and scientific rigor.” It is said to be equipped with the following.
Stephen Hagan can be reached at 978-675-2708 or shagan@gloucestertimes.com.